At the news
? NEUTRALIMPACT 2/10 8-K filed Nov 12, 2026 at 16:30 ET
Olema Pharmaceuticals, Inc. changed its corporate name to Olema Oncology, Inc. via an Eighth Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State, effective November 12, 2026. The company also amended its bylaws to reflect the new name and relocated its principal executive offices from San Francisco to South San Francisco. The common stock continues trading under the same ticker symbol OLMA on Nasdaq.
- Corporate name changed from Olema Pharmaceuticals, Inc. to Olema Oncology, Inc. effective November 12, 2026.
- Eighth Amended and Restated Certificate of Incorporation filed with Delaware Secretary of State.
- Bylaws amended and restated to reflect the name change.
- Principal executive offices relocated from 780 Brannan Street, San Francisco, CA to 365 Oyster Point Blvd., Suite 400, South San Francisco, CA 94080.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access